Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
5 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//PSYCHOLOGY, EXPERIMENTAL | 1830502 |
130 | 3 | EPILEPSY//EPILEPSIA//EPILEPSY & BEHAVIOR | 68382 |
262 | 2 | ANTIEPILEPTIC DRUGS//LEVETIRACETAM//EPILEPSY | 19422 |
9931 | 1 | ANTICONVULSANT ACTIVITY//MAXIMAL ELECTROSHOCK//ANTICONVULSANTS | 1139 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | ANTICONVULSANT ACTIVITY | authKW | 1793344 | 14% | 39% | 165 |
2 | MAXIMAL ELECTROSHOCK | authKW | 568429 | 6% | 31% | 66 |
3 | ANTICONVULSANTS | authKW | 566450 | 21% | 9% | 239 |
4 | EPILEPSY BRANCH | address | 560230 | 5% | 38% | 54 |
5 | MES TEST | authKW | 494075 | 2% | 71% | 25 |
6 | PYRROLIDINE 2 5 DIONE | authKW | 435776 | 2% | 75% | 21 |
7 | DAVID R BLOOM PHARM | address | 299907 | 5% | 20% | 55 |
8 | MAXIMAL ELECTROSHOCK TEST | authKW | 262330 | 1% | 59% | 16 |
9 | SCPTZ TEST | authKW | 251535 | 1% | 91% | 10 |
10 | VALNOCTAMIDE | authKW | 246100 | 1% | 68% | 13 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 24517 | 43% | 0% | 493 |
2 | Pharmacology & Pharmacy | 3767 | 34% | 0% | 392 |
3 | Clinical Neurology | 889 | 13% | 0% | 153 |
4 | Chemistry, Multidisciplinary | 609 | 17% | 0% | 198 |
5 | Chemistry, Organic | 532 | 11% | 0% | 127 |
6 | Crystallography | 294 | 5% | 0% | 56 |
7 | Neurosciences | 29 | 6% | 0% | 65 |
8 | Biochemistry & Molecular Biology | 11 | 8% | 0% | 88 |
9 | Behavioral Sciences | 5 | 1% | 0% | 11 |
10 | Psychiatry | 5 | 2% | 0% | 22 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | EPILEPSY BRANCH | 560230 | 5% | 38% | 54 |
2 | DAVID R BLOOM PHARM | 299907 | 5% | 20% | 55 |
3 | ISOBOLOG ANAL | 226952 | 2% | 37% | 22 |
4 | ANTICONVULSANT DRUG DEV PROGRAM | 162598 | 2% | 26% | 23 |
5 | FOOD DRUG MED | 115286 | 0% | 83% | 5 |
6 | MNDJOYANS FINE ORGAN CHEM | 110676 | 0% | 100% | 4 |
7 | ORGANISM FUNCT TORS CHANGBAI MT | 100389 | 1% | 24% | 15 |
8 | ANTICONVULSANT SCREENING PROGRAM | 90548 | 1% | 55% | 6 |
9 | CORP DEV ASTA MED GRP | 83007 | 0% | 100% | 3 |
10 | PRECLIN PHARMACOL SECT | 72419 | 2% | 11% | 23 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MEDICINAL CHEMISTRY RESEARCH | 29975 | 5% | 2% | 60 |
2 | EPILEPSY RESEARCH | 19297 | 5% | 1% | 53 |
3 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | 17546 | 7% | 1% | 79 |
4 | ARCHIV DER PHARMAZIE | 14557 | 4% | 1% | 48 |
5 | ACTA POLONIAE PHARMACEUTICA | 12303 | 2% | 2% | 26 |
6 | LETTERS IN DRUG DESIGN & DISCOVERY | 10854 | 2% | 2% | 24 |
7 | EPILEPSIA | 10161 | 5% | 1% | 58 |
8 | PHARMACOLOGICAL REPORTS | 8037 | 2% | 1% | 23 |
9 | MEDICINAL CHEMISTRY | 4954 | 1% | 1% | 13 |
10 | JOURNAL OF MEDICINAL CHEMISTRY | 4802 | 5% | 0% | 62 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ANTICONVULSANT ACTIVITY | 1793344 | 14% | 39% | 165 | Search ANTICONVULSANT+ACTIVITY | Search ANTICONVULSANT+ACTIVITY |
2 | MAXIMAL ELECTROSHOCK | 568429 | 6% | 31% | 66 | Search MAXIMAL+ELECTROSHOCK | Search MAXIMAL+ELECTROSHOCK |
3 | ANTICONVULSANTS | 566450 | 21% | 9% | 239 | Search ANTICONVULSANTS | Search ANTICONVULSANTS |
4 | MES TEST | 494075 | 2% | 71% | 25 | Search MES+TEST | Search MES+TEST |
5 | PYRROLIDINE 2 5 DIONE | 435776 | 2% | 75% | 21 | Search PYRROLIDINE+2+5+DIONE | Search PYRROLIDINE+2+5+DIONE |
6 | MAXIMAL ELECTROSHOCK TEST | 262330 | 1% | 59% | 16 | Search MAXIMAL+ELECTROSHOCK+TEST | Search MAXIMAL+ELECTROSHOCK+TEST |
7 | SCPTZ TEST | 251535 | 1% | 91% | 10 | Search SCPTZ+TEST | Search SCPTZ+TEST |
8 | VALNOCTAMIDE | 246100 | 1% | 68% | 13 | Search VALNOCTAMIDE | Search VALNOCTAMIDE |
9 | MES | 233702 | 3% | 24% | 35 | Search MES | Search MES |
10 | SCPTZ | 221344 | 1% | 67% | 12 | Search SCPTZ | Search SCPTZ |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |